ASP Isotopes (NASDAQ:ASPI – Get Free Report) is one of 296 public companies in the “Chemicals” industry, but how does it compare to its rivals? We will compare ASP Isotopes to related businesses based on the strength of its analyst recommendations, risk, profitability, earnings, valuation, dividends and institutional ownership.
Analyst Recommendations
This is a breakdown of recent recommendations and price targets for ASP Isotopes and its rivals, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| ASP Isotopes | 1 | 0 | 2 | 0 | 2.33 |
| ASP Isotopes Competitors | 3277 | 12249 | 14161 | 521 | 2.39 |
ASP Isotopes currently has a consensus price target of $12.00, indicating a potential upside of 736.24%. As a group, “Chemicals” companies have a potential upside of 9.88%. Given ASP Isotopes’ higher probable upside, equities analysts clearly believe ASP Isotopes is more favorable than its rivals.
Risk and Volatility
ASP Isotopes has a beta of 3.77, indicating that its stock price is 277% more volatile than the S&P 500. Comparatively, ASP Isotopes’ rivals have a beta of 0.94, indicating that their average stock price is 6% less volatile than the S&P 500.
Institutional and Insider Ownership
16.8% of ASP Isotopes shares are held by institutional investors. Comparatively, 47.4% of shares of all “Chemicals” companies are held by institutional investors. 14.4% of ASP Isotopes shares are held by insiders. Comparatively, 13.7% of shares of all “Chemicals” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Profitability
This table compares ASP Isotopes and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| ASP Isotopes | -427.98% | -64.99% | -32.20% |
| ASP Isotopes Competitors | -54.13% | -0.60% | -1.36% |
Earnings and Valuation
This table compares ASP Isotopes and its rivals top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| ASP Isotopes | $23.85 million | -$175.09 million | -1.09 |
| ASP Isotopes Competitors | $6.36 billion | $229.42 million | 7.29 |
ASP Isotopes’ rivals have higher revenue and earnings than ASP Isotopes. ASP Isotopes is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Summary
ASP Isotopes rivals beat ASP Isotopes on 9 of the 13 factors compared.
ASP Isotopes Company Profile
ASP Isotopes Inc. is an advanced materials company focused on producing and commercializing enriched isotopes. Its proprietary Aerodynamic Separation Process is designed to separate isotopes and support production across a range of applications. The company’s targeted products include isotopes used in medical imaging and pharmaceuticals, semiconductor manufacturing, quantum technologies and nuclear energy. Examples include molybdenum-100, silicon-28 and ytterbium-176. ASP Isotopes is headquartered in the United States and has pursued isotope-enrichment operations in South Africa.
Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.
